EUVIMEDExplore EUVIMED
Open access

Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings

Kate Bushby, Edward Connor

Clinical Investigation · 2011-09 · 1 (9) · 1217-1235

DOI: 10.4155/cli.11.113 ↗

At a glance

Journal article in Clinical Investigation, 2011-09. Written by Kate Bushby and 1 co-authors. Institution: Institute of Genetic Medicine, International Centre for Life, Newcastle University, Newcastle upon Tyne, UK. Cited 134 times so far (Crossref); 30 references. The full text is freely available in PubMed Central. Funded by: NICHD NIH HHS, NCRR NIH HHS.

AbstractBibliographic detailsCiteRelated studies

Abstract (original language)

In June 2010, 25 representatives from Europe and the US met in Washington, DC, USA, to discuss clinical outcome measures in Duchenne muscular dystrophy (DMD) in the context of clinical trial design and analysis. The workshop was organized in response to a September 2009 European Medicines Agency meeting where a clear directive was given that an international consensus needs to be developed that provides a foundation for age-appropriate clinical outcome measures for use in clinical trials of emerging therapeutics for DMD. Data were presented from eight multicenter longitudinal datasets, representing nearly 1900 patients over a 20-year time period. This experience confirmed the feasibility of repeated evaluations performed at multiple sites and addressed several core issues in drug development for DMD, such as the 'new' natural history in the steroidera, reliability and sensitivity of specific outcome measures, as well as disease staging and patient selection. These data form a valuable asset for academic investigators, pharmaceutical sponsors and regulatory agencies involved in DMD therapeutics. The group remains committed working together on a number of collaborative goals to support the therapeutics development effort in this orphan disease and to make these data available to stakeholders working in the field.

Authors and institutions

  • Institute of Genetic Medicine, International Centre for Life, Newcastle University, Newcastle upon Tyne, UK.

Funding

  • NICHD NIH HHS
  • NCRR NIH HHS

Cite

APA

Bushby, K., & Connor, E. (2011). Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. Clinical Investigation, 1(9), 1217-1235. https://doi.org/10.4155/cli.11.113

Vancouver

Bushby K, Connor E. Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. Clinical Investigation. 2011;1(9):1217-1235. doi:10.4155/cli.11.113

BibTeX
@article{Bushby2011,
  author = {Bushby, Kate and Connor, Edward},
  title = {Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings},
  journal = {Clinical Investigation},
  year = {2011},
  volume = {1},
  number = {9},
  pages = {1217--1235},
  doi = {10.4155/cli.11.113}
}
Start for free →